Revision history of "Investigation of the predictive and prognostic role of liquid biopsies in patients with non-small cell lung cancer treated with anti-PD-1-inhibitor, pembrolizumab" (Q2720782)

10 October 2024

• curprev 08:0608:06, 10 October 2024‎ DG Regio talk contribs‎ 79,063 bytes +1‎ ‎Changed label, description and/or aliases in pt
• curprev 08:0608:06, 10 October 2024‎ DG Regio talk contribs‎ 79,062 bytes +90‎ ‎Set a claim value: summary (P836): Apesar dos novos tratamentos, o prognóstico dos pacientes com cancro do pulmão de não-pequenas células (NSP) permanece pobre. A utilização de inibidores da imunoterapia ou da imunoresposta, como o pembrolizumab, foi testada em doentes com INN cujos tumores expressam PD-L1. Atualmente, o biomarcador prognóstico para o uso de inibidores anti-PD1/anti-PD-L1 é a imuno-histoquímica para detecção de PD-L1. Contudo, o método apresenta problemas como o dese...

22 March 2024

• curprev 16:3616:36, 22 March 2024‎ DG Regio talk contribs‎ 78,972 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.7299061271137002

10 July 2022

• curprev 21:5321:53, 10 July 2022‎ DG Regio talk contribs‎ 78,684 bytes +49,526‎ ‎Changed label, description and/or aliases in da, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, el, it, es, and other parts: Adding translations: da, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,

12 January 2022

• curprev 18:1418:14, 12 January 2022‎ DG Regio talk contribs‎ 29,158 bytes +3,091‎ ‎Changed label, description and/or aliases in es, and other parts: Adding Spanish translations

11 January 2022

• curprev 10:5010:50, 11 January 2022‎ DG Regio talk contribs‎ 26,067 bytes +2,994‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

29 November 2021

• curprev 10:1010:10, 29 November 2021‎ DG Regio talk contribs‎ 23,073 bytes +2,794‎ ‎Created claim: summary (P836): Ondanks nieuwe behandelingen blijft de prognose van patiënten met niet-kleincellige longkanker (NSCLC) slecht. Het gebruik van immunotherapie of immunoresponsremmers zoals pembrolizumab is getest bij patiënten met NSCCP bij wie tumoren PD-L1 uitdrukken. Momenteel is de voorspellende biomarker voor het gebruik van anti-PD1/anti-PD-L1-remmers immunohistochemie voor PD-L1-detectie. De methode levert echter problemen op zoals de prestaties van versc...
• curprev 10:1010:10, 29 November 2021‎ DG Regio talk contribs‎ 20,279 bytes +232‎ ‎Changed label, description and/or aliases in nl: translated_label
• curprev 07:3107:31, 29 November 2021‎ DG Regio talk contribs‎ 20,047 bytes +2,823‎ ‎Created claim: summary (P836): Trotz neuer Behandlungen ist die Prognose von Patienten mit nicht-kleinzelligem Lungenkrebs (NSCLC) nach wie vor schlecht. Die Anwendung von Immuntherapie oder Immunsponsionsinhibitoren wie Pembrolizumab wurde bei Patienten mit NSCCP getestet, deren Tumore PD-L1 ausdrücken. Derzeit ist der prädiktive Biomarker für die Anwendung von Anti-PD1/Anti-PD-L1-Inhibitoren immunohistochemistry für den PD-L1-Detektion. Die Methode stellt jedoch Probleme wi...
• curprev 07:3107:31, 29 November 2021‎ DG Regio talk contribs‎ 17,224 bytes +241‎ ‎Changed label, description and/or aliases in de: translated_label

27 November 2021

• curprev 11:5211:52, 27 November 2021‎ DG Regio talk contribs‎ 16,983 bytes +3,037‎ ‎Created claim: summary (P836): Malgré de nouveaux traitements, le pronostic des patients atteints d’un cancer du poumon non à petites cellules (LCPNC) reste médiocre. L’utilisation d’immunothérapie ou d’inhibiteurs de l’immunoréponse comme le pembrolizumab a été testée chez des patients atteints de NSCCP dont les tumeurs expriment la PD-L1. Actuellement, le biomarqueur prédictif pour l’utilisation d’inhibiteurs anti-PD1/anti-PD-L1 est l’immunohistochimie pour la détection de...
• curprev 11:0111:01, 27 November 2021‎ DG Regio talk contribs‎ 13,946 bytes −2,615‎ ‎Removed claim: summary (P836): Παρ▲ σις νσες ▲εραπεσες, η πρ″σν ασση ασσενμεμη μισροσσαρι″αρι″ σαρ σσσνο πννεσμοονα (εσΠ) παραμσνει αι α φ H χρ Επσσσισι βιοσι-PD1/ρ-L-L1, εσν ασοσοσοσοχμεσα για α-PD-L1, εσνα η ανοσοσοσοχημεσα εια ανεσσα φι ανεσσα για ανια ανια ανεσσα σια ανεση φο α PD-L1. Ωσ″σσο, η μ″σοσος παροσσι″ει προβλ″μασα ▲πσοσοση σιαφορεσον ανισσν αισσσν Επσσης, η ▲φφραση σο″ PD-L1 παροσι″ει χρορονι ▲Ε αν αν″σεση, οι Õι σσρσς βιοσσες, ▲πσς σα ″α σλοφοροσα σαρορινι″ χ...
• curprev 09:5509:55, 27 November 2021‎ DG Regio talk contribs‎ 16,561 bytes +2,615‎ ‎Created claim: summary (P836): Παρ▲ σις νσες ▲εραπεσες, η πρ″σν ασση ασσενμεμη μισροσσαρι″αρι″ σαρ σσσνο πννεσμοονα (εσΠ) παραμσνει αι α φ H χρ Επσσσισι βιοσι-PD1/ρ-L-L1, εσν ασοσοσοσοχμεσα για α-PD-L1, εσνα η ανοσοσοσοχημεσα εια ανεσσα φι ανεσσα για ανια ανια ανεσσα σια ανεση φο α PD-L1. Ωσ″σσο, η μ″σοσος παροσσι″ει προβλ″μασα ▲πσοσοση σιαφορεσον ανισσν αισσσν Επσσης, η ▲φφραση σο″ PD-L1 παροσι″ει χρορονι ▲Ε αν αν″σεση, οι Õι σσρσς βιοσσες, ▲πσς σα ″α σλοφοροσα σαρορινι″ χρη...
• curprev 09:1909:19, 27 November 2021‎ DG Regio talk contribs‎ 13,946 bytes +244‎ ‎Changed label, description and/or aliases in fr: translated_label

24 June 2021

• curprev 12:1612:16, 24 June 2021‎ DG Regio talk contribs‎ 13,702 bytes +433‎ ‎Changed an Item

21 June 2021

• curprev 09:2009:20, 21 June 2021‎ DG Regio talk contribs‎ 13,269 bytes +431‎ ‎Changed an Item

31 May 2021

• curprev 19:2519:25, 31 May 2021‎ DG Regio talk contribs‎ 12,838 bytes +2,509‎ ‎Created claim: summary (P836): Despite new treatments, the prognosis of patients with non-small cell lung cancer (NSP) remains poor. The use of immunotherapy or immunoresponse inhibitors such as pembrolizumab has been tested in patients with NMIs whose tumors express PD-L1. Currently, the prognostic biomarker for the use of anti-PD1/anti-PD-L1 inhibitors is immunohistochemistry to detect PD-L1. However, the method presents problems such as the performance of different antibod...
• curprev 18:3818:38, 31 May 2021‎ DG Regio talk contribs‎ 10,329 bytes +3,947‎ ‎Changed an Item
• curprev 18:3818:38, 31 May 2021‎ DG Regio talk contribs‎ 6,382 bytes −1,704‎ ‎Removed claims
• curprev 18:3518:35, 31 May 2021‎ DG Regio talk contribs‎ 8,086 bytes +222‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 18:3518:35, 31 May 2021‎ DG Regio talk contribs‎ 7,864 bytes +984‎ ‎Created claim: summary (P836): Investigation of the predictive and prognostic role of liquid biopsies in patients with non-small cell lung cancer treated with anti-PD-1-inhibitor, pembrolizumab, translated_summary
• curprev 14:5414:54, 31 May 2021‎ DG Regio talk contribs‎ 6,880 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 14:5414:54, 31 May 2021‎ DG Regio talk contribs‎ 6,890 bytes +6,890‎ ‎Created a new Item